Skip to main content
. 2022 Jun 19;10(6):e5949. doi: 10.1002/ccr3.5949

FIGURE 5.

FIGURE 5

Data of nutritional status. R‐THP‐COP, rituximab, pirarubicin, cyclophosphamide, prednisolone; Pola‐BR, polatuzumab vedotin, bendamustine, rituximab; R‐GDC, rituximab, gemcitabine, dexamethasone, carboplatin. Inline graphic, 30 Gy/10 fractions